Indivior stock pre-market at EUR 32.10: plus 0.00 percent
Published on 10/06/2026 at 08:37 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Indivior stock was unchanged pre-market at EUR 32.10 at 8:35 a.m. CEST on October 6, 2026, according to Lang & Schwarz. The price was unchanged at plus 0.00 percent versus the Lang & Schwarz prior close of EUR 32.10 on October 5, 2026.
Pre-market trading
Lang & Schwarz listed a bid of EUR 31.20 and an ask of EUR 33.00 for Indivior at the recorded time. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of Indivior stock.
Contingent special dividend
In a September 17, 2026 release, GlobeNewswire reported that Indivior Pharmaceuticals, Inc. declared a special cash dividend of USD 8.13 per share for holders of record on October 30, 2026. Payment is contingent on the closing of Indivior's merger with Supernus Pharmaceuticals, which the company expected on or about November 2, 2026.
Indivior said the dividend would not be paid if the merger is not completed. Assuming a November 2 closing, payment to eligible record holders was anticipated on or about November 6, 2026. The SEC filing also identifies Indivior Pharmaceuticals, Inc. common stock under the ticker INDV on The Nasdaq Stock Market.
Regulatory filing
Indivior disclosed the dividend declaration and its conditions in a September 16, 2026 Form 8-K report filed with the U.S. Securities and Exchange Commission.
